stockportfolio.pro
Prestige Consumer Healthcare Inc. P/E Ratio 2010–2026
Prestige Consumer Healthcare Inc. (PBH) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +0.5%/yr over 16 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2026 | 15.16 | -24.4% |
| FY 2025 | 20.04 | +15.2% |
| FY 2024 | 17.40 | — |
| FY 2023 | — | — |
| FY 2022 | 13.10 | -3.4% |
| FY 2021 | 13.56 | +2.8% |
| FY 2020 | 13.19 | — |
| FY 2019 | — | — |
| FY 2018 | 5.32 | -87.6% |
| FY 2017 | 42.74 | +50.5% |
| FY 2016 | 28.40 | -1.3% |
| FY 2015 | 28.79 | +46.8% |
| FY 2014 | 19.60 | -3.1% |
| FY 2013 | 20.23 | -15.5% |
| FY 2012 | 23.95 | +20.8% |
| FY 2011 | 19.83 | +41.0% |
| FY 2010 | 14.06 | — |
Source: Prestige Consumer Healthcare Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Prestige Consumer Healthcare Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePrestige Consumer Healthcare Inc. — frequently asked questions
What is Prestige Consumer Healthcare Inc.'s price-to-earnings ratio?
Prestige Consumer Healthcare Inc. (PBH) reported price-to-earnings ratio of 15.16 for fiscal year 2026, per its SEC filings.
How has Prestige Consumer Healthcare Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2010 and 2026, PBH's price-to-earnings ratio grew at roughly 0.5% per year (compound annual rate), from 14.06 to 15.16.
Where does this data come from?
Figures are computed from Prestige Consumer Healthcare Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.